A biotech startup insideLilly Research Labs
At Protomer, we’re working to build a future of smarter medicines – medicines that can dynamically modify their activity in the body to increase their potency where or when they’re needed.
Better medicines together
In 2021, Protomer was acquired by Eli Lilly and Company. As a wholly-owned subsidiary, we’ve married the agility and audacity of a biotech startup with the history and impact of a global pharmaceutical company.
Alexandria Real Estate Equities, Inc. Photo used with permission.
Founded by Caltech alumni and faculty, Protomer is located in sunny Pasadena, California
We aim for medicines that are especially potent where or when you need them
Our team
Alborz Mahdavi, PhD
CEO
Alborz Mahdavi, PhD
CEO
Danielle Sumilang
Biology
Danielle Sumilang
Biology
Delaney Foo
Biochemistry
Delaney Foo
Biochemistry
Diao Chen, PhD
Chemistry
Diao Chen, PhD
Chemistry
Ganesh Sable, PhD
Chemistry
Ganesh Sable, PhD
Chemistry
Jack Steele
COO
Nisi cras donec primis tincidunt vulputate dictum at semper augue potenti venenatis habitant est ullamcorper senectus aliquam, fringilla dui sollicitudin arcu hendrerit dignissim nunc viverra vel mi porta neque blandit aptent.
Jack Steele
COO
Julie Sinclair, PhD
Chemistry
Julie Sinclair, PhD
Chemistry
Natalie Elmasry
Chemistry
Natalie Elmasry
Chemistry
Phillip Kim
Chemistry
Phillip Kim
Chemistry
Ryan Spencer, PhD
Chemistry
Ryan Spencer, PhD
Chemistry
Sachin Mali, PhD
Chemistry
Sachin Mali, PhD
Chemistry
Thomas Hoeg-Jensen, PhD
Chemistry
Thomas Hoeg-Jensen, PhD
Chemistry
Tyler Yeomans
Chemistry
Tyler Yeomans
Chemistry
Zenas Heng
Chemistry
Zenas Heng
Chemistry
“Lorem ipsum dolor sit amet, consect adipiscing elit, sed do eiusmod tempor incididunt ut labore et. Lorem ipsum dolor sit amet, consect adipiscing elit, sed do eiusmod tempor incididunt ut labore et.”
Danielle Doe
Chemistry